Human gene therapy - JoVE Visualize

Showing results (2051-2060 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|August 24, 2000

Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207M Oyama, T Ohigashi, M Hoshi, et al.

Human Gene Therapy|August 24, 2000

Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditionsM A Croyle, Q C Yu, J M Wilson

Human Gene Therapy|July 26, 2000

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragmentS Paul, D Snary, J Hoebeke, et al.

Human Gene Therapy|July 26, 2000

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental gliomaU Herrlinger, A Jacobs, A Quinones, et al.

Human Gene Therapy|July 26, 2000

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplantsK G Lucas, Q Sun, R L Burton, et al.

Human Gene Therapy|December 19, 2001

Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicityA Kianmanesh, N R Hackett, J M Lee, et al.

Human Gene Therapy|January 29, 2002

Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumorVivian Wai Yan Lui, Yukai He, Louis Falo, et al.

Human Gene Therapy|January 29, 2002

Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activatorsStefania Lamartina, Giuseppe Roscilli, Cira Daniela Rinaudo, et al.

Human Gene Therapy|January 10, 2002

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particlesH Li, Y S Haviv, C A Derdeyn, et al.

Human Gene Therapy|January 10, 2002

Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injuryM D Wheeler, M Katuna, O M Smutney, et al.

Pageof 413

Showing results (2051-2060 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|August 24, 2000

Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207M Oyama, T Ohigashi, M Hoshi, et al.

Human Gene Therapy|August 24, 2000

Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditionsM A Croyle, Q C Yu, J M Wilson

Human Gene Therapy|July 26, 2000

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragmentS Paul, D Snary, J Hoebeke, et al.

Human Gene Therapy|July 26, 2000

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental gliomaU Herrlinger, A Jacobs, A Quinones, et al.

Human Gene Therapy|July 26, 2000

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplantsK G Lucas, Q Sun, R L Burton, et al.

Human Gene Therapy|December 19, 2001

Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicityA Kianmanesh, N R Hackett, J M Lee, et al.

Human Gene Therapy|January 29, 2002

Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumorVivian Wai Yan Lui, Yukai He, Louis Falo, et al.

Human Gene Therapy|January 29, 2002

Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activatorsStefania Lamartina, Giuseppe Roscilli, Cira Daniela Rinaudo, et al.

Human Gene Therapy|January 10, 2002

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particlesH Li, Y S Haviv, C A Derdeyn, et al.

Human Gene Therapy|January 10, 2002

Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injuryM D Wheeler, M Katuna, O M Smutney, et al.

Pageof 413